[Mo]

I do agree stakeholder should be involved from early stages in HIV prevention trials on, although I think it is not so easy to define all stakeholders. Hope to learn a lot during the training course.

An other item I would like to bring up has to do with  the first assignment, to describe the HIV epidemic in your community. As I am an employee of a global pharmaceutical company, living in the Netherlands, I am not so sure how to interpret this question. Our HIV prevention trial scope is global, not restricted to a certain country or community.  Anybody else who has the same question or any suggestion from the group?

[Author]

Replies